Mp88-09 Preclinical Model of Dual-Specific, Mtor Complex 1 (Torc1) and Mtor Complex 2 (Torc2) Inhibitors for Bladder Cancer Treatment
Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.2427
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)